PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 23 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
An aqueous extract attenuated postprandial hyperglycemia and was effective for controlling fasting and postprandial blood glucose levels in diabetic mice [PMID:22587572].
A soluble-methanol extract (MEBc) at 100mg/Kg showed significant anxiolytic-like effects in mice models [PMID:27381041].
Lyophilized tea extracts and specific identified compounds inhibited the proliferation of human carcinoma liver (HepG2) cells in a concentration-dependent manner [PMID:24962327].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 22587572 (2012) — α-glucosidase inhibitors from Brickellia cavanillesii. · Journal of natural products
- 2.PMID: 27381041 (2016) — Anxiolytic-like effects and toxicological studies of Brickellia cavanillesii (Cass.) A. Gray in experimental mice models. · Journal of ethnopharmacology
- 3.PMID: 24962327 (2014) — Lyophilized tea extracts of Brickellia cavanillesii (Asteraceae): in vitro characterization of biological activity. · Journal of food science
- 4.PMID: 23398496 (2013) — Mexican antidiabetic herbs: valuable sources of inhibitors of α-glucosidases. · Journal of natural products
- 5.PMID: 24804069 (2014) — Chemical characterization of Brickellia cavanillesii (Asteraceae) using gas chromatographic methods.